NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
Description
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
Offer reference number: CM/PHG/24/5716
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028
The rest of this notice
The tender documents, the buyer's named contact and the award history for this notice are free. Create an account to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Get alerts for tenders like this one
Free — no card, no trial clock.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.